Proton pump inhibitors use and risk of inflammatory bowel diseases: a meta-analysis of observational studies

BACKGROUND AND OBJECTIVE: Proton Pump Inhibitors (PPIs) reduce gastric acid production and they are indicated for myriad gastrointestinal conditions. Prolonged use of PPI has been linked to the risk of inflammatory bowel disease (IBD) though this fact is not well established. We aimed to conduct a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Shastri, Sanjana Aditya, Kantamneni, Raveena, Rashid, Muhammed, Chandran, Viji Pulikkel, Suhita, Ramadugula, Begum, Izwath, Nair, Sreedharan, Thunga, Girish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694755/
https://www.ncbi.nlm.nih.gov/pubmed/36506599
http://dx.doi.org/10.15386/mpr-2259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694755/
https://www.ncbi.nlm.nih.gov/pubmed/36506599
http://dx.doi.org/10.15386/mpr-2259

Ejemplares similares